Global Oncology Preclinical Drug Developers 2021, is specially designed to identify early stage researchers, having new ideas capable of changing the face of drug discovery. It covers entrepreneurs established in last few years with valid funding and clear demarked pipeline and covers Individual’s Technology, Management, Funding and Partnering capabilities.

Report covers largest set of authentic early stage oncology drug developers worldwide with early stage molecules available for partnering and is a perfect tool to identify new partnering leads.